Kala Pharmaceuticals Inc. Stock
A loss of -1.600% shows a downward development for Kala Pharmaceuticals Inc..
We see a rather positive sentiment for Kala Pharmaceuticals Inc. with 10 Buy predictions and 1 Sell predictions.
With a target price of 10 € there is potential for a 5334.78% increase which would mean more than doubling the current price of 0.18 € for Kala Pharmaceuticals Inc..
Our community identified positive and negative aspects for Kala Pharmaceuticals Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the Kala Pharmaceuticals Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -1.600% | 32.847% | -18.459% | -93.860% | -62.178% | -98.833% | -99.940% |
| Heron Therapeutics Inc. | 2.240% | 10.879% | -0.581% | -54.196% | -30.925% | -70.630% | -94.480% |
| Evolus Inc | -0.540% | 3.399% | -16.590% | -59.326% | -33.578% | -51.733% | -63.061% |
| Sangamo Therapeutics Inc. | 4.140% | -2.426% | -34.637% | -67.260% | -37.907% | -85.570% | -97.764% |
Comments
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at HC Wainwright from $12.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $15.00 to $33.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat